Home Diagnostic testing for a high-grade inflammation: parameter dynamics and novel markers
Article
Licensed
Unlicensed Requires Authentication

Diagnostic testing for a high-grade inflammation: parameter dynamics and novel markers

  • Christina Hoffmann ORCID logo EMAIL logo , Peter Hoffmann and Mathias Zimmermann
Published/Copyright: August 7, 2014
Become an author with De Gruyter Brill
Submit Manuscript Author Information
Clinical Chemistry and Laboratory Medicine (CCLM)
From the journal Clinical Chemistry and Laboratory Medicine (CCLM) Volume 53 Issue 4

Abstract

Background: The timely detection of severe inflammatory conditions is of great importance for early therapy initiation and the patient’s prognosis. The complex humoral and cellular processes involved in inflammation offer many opportunities for diagnostic testing, which are still unused in clinical practice. We investigated the dynamics of four established and two novel potential markers during the onset and resolution of a high-grade inflammation.

Methods: We retrospectively analyzed C-reactive protein and procalcitonin concentrations, leukocyte and thrombocyte counts, granularity index, and δ-hemoglobin measured in peripheral blood samples of patients undergoing inflammation diagnostics between September 2010 and November 2010. Data from a consecutive sample of 53,968 patients were available.

Results: Trajectories for the parameters’ dynamics during the onset and resolution of a high-grade inflammation were calculated with a locally weighted scatter plot smoothing method. The leukocyte count trajectories did not exceed the reference range.

Conclusions: We were able to elucidate the parameter dynamics with time coordinates rounded to the nearest hour and a follow-up of 168 h.

Keywords: acute phase reaction; clinical laboratory techniques; critical care
Corresponding author: Christina Hoffmann, Charité – Universitätsmedizin Berlin, Institut für Laboratoriumsmedizin, Klinische Chemie und Pathobiochemie, Augustenburger Platz 1, 13353 Berlin, Deutschland, Phone: +49 30 450569034, Fax: +49 30 450569900, E-mail: .
aChristina Hoffmann and Peter Hoffmann contributed equally to this work.

Acknowledgments

We thank Jose B. Gonzalez for his input to study conception. We are further grateful to Henrik Schmidt for his assistance with data processing.

Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

Financial support: None declared.

Employment or leadership: None declared.

Honorarium: M.Z. received a travel grant from Sysmex Deutschland GmbH.

Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. Angus DC, van der Poll T. Severe sepsis and septic shock. N Engl J Med 2013;369:840–51.10.1056/NEJMra1208623Search in Google Scholar PubMed

2. Paul M, Shani V, Muchtar E, Kariv G, Robenshtok E, Leibovici L. Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis. Antimicrob Agents Chemother 2010;54:4851–63.10.1128/AAC.00627-10Search in Google Scholar PubMed PubMed Central

3. Stuart J, Whicher JT. Tests for detecting and monitoring the acute phase response. Arch Dis Child 1988;63:115–7.10.1136/adc.63.2.115Search in Google Scholar PubMed PubMed Central

4. Di Napoli M, Godoy DA, Campi V, Masotti L, Smith CJ, Parry Jones AR, et al. C-reactive protein in intracerebral hemorrhage: time course, tissue localization, and prognosis. Neurology 2012;79:690–9.10.1212/WNL.0b013e318264e3beSearch in Google Scholar PubMed

5. Pinato DJ, Bains J, Irkulla S, Pomroy J, Ujam B, Gaze D, et al. Advanced age influences the dynamic changes in circulating C-reactive protein following injury. J Clin Pathol 2013;66:695–9.10.1136/jclinpath-2012-201374Search in Google Scholar PubMed

6. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999;340:448–54.10.1056/NEJM199902113400607Search in Google Scholar PubMed

7. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003;31:1250–6.10.1097/01.CCM.0000050454.01978.3BSearch in Google Scholar PubMed

8. Kugel MA, Rosenthal N. Pathologic changes occurring in polymorphonuclear leukocytes during the progress of infections. Am J Med Sci 1932;183:657–67.10.1097/00000441-193205000-00008Search in Google Scholar

9. Zimmermann M, Cremer M, Hoffmann C, Weimann K, Weimann A. Granularity index of the Sysmex XE-5000 hematology analyzer as a replacement for manual microscopy of toxic granulation neutrophils in patients with inflammatory diseases. Clin Chem Lab Med 2011;49:1193–8.10.1515/CCLM.2011.188Search in Google Scholar PubMed

10. Luo Y, Lin J, Chen H, Zhang J, Peng S, Kuang M. Utility of neut-x, neut-y and neut-z parameters for rapidly assessing sepsis in tumor patients. Clin Chim Acta 2013;422:5–9.10.1016/j.cca.2013.03.026Search in Google Scholar PubMed

11. Le Roux G, Vlad A, Eclache V, Malanquin C, Collon JF, Gantier M, et al. Routine diagnostic procedures of myelodysplastic syndromes: value of a structural blood cell parameter (neut-x) determined by the Sysmex XE-2100. Int J Lab Hematol 2010;32:e237–43.10.1111/j.1751-553X.2010.01247.xSearch in Google Scholar PubMed

12. Furundarena JR, Araiz M, Uranga M, Sainz MR, Agirre A, Trassorras M, et al. The utility of the Sysmex XE-2100 analyzer’s neut-x and neut-y parameters for detecting neutrophil dysplasia in myelodysplastic syndromes. Int J Lab Hematol 2010;32:360–6.10.1111/j.1751-553X.2009.01194.xSearch in Google Scholar PubMed

13. Ganz T, Nemeth E. Hepcidin and iron homeostasis. Biochim Biophys Acta 2012;1823:1434–43.10.1016/j.bbamcr.2012.01.014Search in Google Scholar PubMed PubMed Central

14. Schoorl M, Snijders D, Schoorl M, Boersma WG, Bartels PC. Transient impairment of reticulocyte hemoglobin content and hepcidin-25 induction in patients with community- acquired pneumonia. Scand J Clin Lab Invest 2013;73: 54–60.10.3109/00365513.2012.735694Search in Google Scholar PubMed

15. Urrechaga E, Borque L, Escanero JF. Biomarkers of hypochromia: the contemporary assessment of iron status and erythropoiesis. Biomed Res Int 2013;2013:603786.10.1155/2013/603786Search in Google Scholar PubMed PubMed Central

16. Brugnara C, Mohandas N. Red cell indices in classification and treatment of anemias: from M.M. Wintrobes’s original 1934 classification to the third millennium. Curr Opin Hematol 2013;20:222–30.10.1097/MOH.0b013e32835f5933Search in Google Scholar PubMed

17. Thomas L, editor. Labor und Diagnose: Indikation und Bewertung von Laborbefunden für die medizinische Diagnostik, 8th ed. Frankfurt/Main: Th-Books Verl.-Ges., 2012:1279.Search in Google Scholar

18. Cleveland WS. Robust locally weighted regression and smoothing scatterplots. J Am Statist Ass 1979;74:829–36.10.1080/01621459.1979.10481038Search in Google Scholar

19. Reinhart K, Meisner M, Brunkhorst FM. Markers for sepsis diagnosis: what is useful? Crit Care Clin 2006;22:503–19, ix–x.10.1016/j.ccc.2006.03.003Search in Google Scholar PubMed

20. Jekarl DW, Lee SY, Lee J, Park YJ, Kim Y, Park JH, et al. Procalcitonin as a diagnostic marker and IL-6 as a prognostic marker for sepsis. Diagn Microbiol Infect Dis 2013;75:342–7.10.1016/j.diagmicrobio.2012.12.011Search in Google Scholar PubMed

21. Grewal PK, Uchiyama S, Ditto D, Varki N, Le DT, Nizet V, et al. The Ashwell receptor mitigates the lethal coagulopathy of sepsis. Nat Med 2008;14:648–55.10.1038/nm1760Search in Google Scholar PubMed PubMed Central

22. Bates DW, Cook EF, Goldman L, Lee TH. Predicting bacteremia in hospitalized patients. A prospectively validated model. Ann Intern Med 1990;113:495–500.10.7326/0003-4819-113-7-495Search in Google Scholar PubMed

Received: 2014-5-5
Accepted: 2014-7-4
Published Online: 2014-8-7
Published in Print: 2015-3-1

©2015 by De Gruyter

Articles in the same Issue

  1. Frontmatter
  2. Editorials
  3. “Personalized” sepsis care with the help of specific biomarker levels on admission and during follow up: are we there yet?
  4. Procalcitonin-guided antibiotic therapy: a potentially effective and efficient strategy
  5. Review
  6. The prognostic blood biomarker proadrenomedullin for outcome prediction in patients with chronic obstructive pulmonary disease (COPD): a qualitative clinical review
  7. General Clinical Chemistry and Laboratory Medicine
  8. Diagnostic testing for a high-grade inflammation: parameter dynamics and novel markers
  9. Serial changes in serum procalcitonin, interleukin 6, and C-reactive protein levels according to non-specific surgical stimulation
  10. Utility of procalcitonin, C-reactive protein and white blood cells alone and in combination for the prediction of clinical outcomes in community-acquired pneumonia
  11. Presepsin as a potential marker for bacterial infection relapse in critical care patients. A preliminary study
  12. Diagnosis and evaluation of severity of sepsis via the use of biomarkers and profiles of 13 cytokines: a multiplex analysis
  13. Economic evaluation of procalcitonin-guided antibiotic therapy in acute respiratory infections: a US health system perspective
  14. Analytical evaluation of Diazyme procalcitonin (PCT) latex-enhanced immunoturbidimetric assay on Beckman Coulter AU5800
  15. Calprotectin and lactoferrin in the cerebrospinal fluid; biomarkers utilisable for differential diagnostics of bacterial and aseptic meningitis?
  16. Cancer Diagnostics
  17. Increased level of circulating U2 small nuclear RNA fragments indicates metastasis in melanoma patients
  18. Cardiovascular Diseases
  19. Comparison between admission natriuretic peptides, NGAL and sST2 testing for the prediction of worsening renal function in patients with acutely decompensated heart failure
  20. Diabetes
  21. Weight loss reduces serum monocyte chemoattractant protein-1 concentrations in association with improvements in renal injury in obese men with metabolic syndrome
  22. Letters to the Editors
  23. Ranking prestige of medical and laboratory technology journals
  24. Expression of CD64 on neutrophils (CD64 index): diagnostic accuracy of CD64 index to predict sepsis in critically ill patients
  25. Measurement of apolipoprotein M in sepsis-related deaths
  26. The stability of select biomarkers in frozen plasma over time: an evaluation of a low-volume sample analyzer
  27. Is the new Beckman AccuTnI+3 assay capable of producing false-positive troponin I results?
  28. Spectrum of red cell abnormalities in undiagnosed hemolytic anemias and methemoglobinemias: a single center experience
  29. Correlation of methadone concentrations in plasma and saliva collected with and without stimulation in pain management patients
  30. Higher alkaline phosphatase was associated with the short-term adverse outcomes of peritoneal dialysis-related peritonitis
  31. The use of a rapid fluorogenic neuraminidase assay to differentiate acute Streptococcus pneumoniae-associated hemolytic uremic syndrome (HUS) from other forms of HUS
  32. Congress Abstracts
  33. 3rd EFLM-BD European Conference on Preanalytical Phase
https://doi.org/10.1515/cclm-2014-0482
Keywords for this article
acute phase reaction; clinical laboratory techniques; critical care

Articles in the same Issue

  1. Frontmatter
  2. Editorials
  3. “Personalized” sepsis care with the help of specific biomarker levels on admission and during follow up: are we there yet?
  4. Procalcitonin-guided antibiotic therapy: a potentially effective and efficient strategy
  5. Review
  6. The prognostic blood biomarker proadrenomedullin for outcome prediction in patients with chronic obstructive pulmonary disease (COPD): a qualitative clinical review
  7. General Clinical Chemistry and Laboratory Medicine
  8. Diagnostic testing for a high-grade inflammation: parameter dynamics and novel markers
  9. Serial changes in serum procalcitonin, interleukin 6, and C-reactive protein levels according to non-specific surgical stimulation
  10. Utility of procalcitonin, C-reactive protein and white blood cells alone and in combination for the prediction of clinical outcomes in community-acquired pneumonia
  11. Presepsin as a potential marker for bacterial infection relapse in critical care patients. A preliminary study
  12. Diagnosis and evaluation of severity of sepsis via the use of biomarkers and profiles of 13 cytokines: a multiplex analysis
  13. Economic evaluation of procalcitonin-guided antibiotic therapy in acute respiratory infections: a US health system perspective
  14. Analytical evaluation of Diazyme procalcitonin (PCT) latex-enhanced immunoturbidimetric assay on Beckman Coulter AU5800
  15. Calprotectin and lactoferrin in the cerebrospinal fluid; biomarkers utilisable for differential diagnostics of bacterial and aseptic meningitis?
  16. Cancer Diagnostics
  17. Increased level of circulating U2 small nuclear RNA fragments indicates metastasis in melanoma patients
  18. Cardiovascular Diseases
  19. Comparison between admission natriuretic peptides, NGAL and sST2 testing for the prediction of worsening renal function in patients with acutely decompensated heart failure
  20. Diabetes
  21. Weight loss reduces serum monocyte chemoattractant protein-1 concentrations in association with improvements in renal injury in obese men with metabolic syndrome
  22. Letters to the Editors
  23. Ranking prestige of medical and laboratory technology journals
  24. Expression of CD64 on neutrophils (CD64 index): diagnostic accuracy of CD64 index to predict sepsis in critically ill patients
  25. Measurement of apolipoprotein M in sepsis-related deaths
  26. The stability of select biomarkers in frozen plasma over time: an evaluation of a low-volume sample analyzer
  27. Is the new Beckman AccuTnI+3 assay capable of producing false-positive troponin I results?
  28. Spectrum of red cell abnormalities in undiagnosed hemolytic anemias and methemoglobinemias: a single center experience
  29. Correlation of methadone concentrations in plasma and saliva collected with and without stimulation in pain management patients
  30. Higher alkaline phosphatase was associated with the short-term adverse outcomes of peritoneal dialysis-related peritonitis
  31. The use of a rapid fluorogenic neuraminidase assay to differentiate acute Streptococcus pneumoniae-associated hemolytic uremic syndrome (HUS) from other forms of HUS
  32. Congress Abstracts
  33. 3rd EFLM-BD European Conference on Preanalytical Phase
Sign up now to receive a 20% welcome discount
Institutional Access
How does access work?
Have an idea on how to improve our website?
Please write us.
© 2025 De Gruyter Brill
Downloaded on 16.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/cclm-2014-0482/html?lang=en
Scroll to top button